Last reviewed · How we verify
Inavir (laninamivir octanoate hydrate)
At a glance
| Generic name | laninamivir octanoate hydrate |
|---|---|
| Sponsor | Daiichi Sankyo |
| Drug class | laninamivir |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Influenza
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inavir CI brief — competitive landscape report
- Inavir updates RSS · CI watch RSS
- Daiichi Sankyo portfolio CI